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Abstract
Rationale The acne drug isotretinoin has 13-cis retinoic
acid as its active agent. Adverse effects that have been
described include severe depression. Animal studies indi-
cate that the hippocampus is particularly sensitive to retinoic
acid. Changes induced by isotretinoin to hippocampal func-
tion could contribute to depression but may be more evident
in altered visuospatial learning and memory, the primary
function of the hippocampus.
Objectives We aimed to test the hypothesis that a course of
oral isotretinoin therapy would result in declining visuospa-
tial learning and memory.
Methods CANTAB tasks designed to assess visuospatial
memorywereperformedrepeatedlyon14malesand3females
in an open prospective observational study of patients with
severe acne undergoing isotretinoin therapy. Beck’s Depres-
sionInventoryand GlobalAcneGrade were also administered.
Results Performance stayed unchanged for DMS, SRM and
PRM tasks, while surprisingly participants improved their
speed on the PRM task. Performance improved across ses-
sions on the PAL task, and moreover the dose of isotretinoin
correlated with improvement in the total trial score, reduc-
tion in total error rate and stage completed at the first trial.
Conclusion Isotretinoin does not reduce learning and mem-
ory and our study suggests that it may instead lead to a dose-
related improvement in specific aspects of hippocampal
learning and memory. Retinoic acid functions in the hippo-
campus as the active metabolite of vitamin A, suggesting
that this may be a limiting factor in the human hippocampus
and addition of exogenous retinoic acid brings levels closer
to an optimal state.
Keywords Isotretinoin.Retinoicacid.Memory.Learning.
Hippocampus.CANTAB
Introduction
Isotretinoin (13-cis retinoic acid, 13-cis RA) has been an
effective treatment for acne since its introduction in 1982.
This drug acts to suppress acne in multiple ways, reducing
sebaceous gland secretion and size, possibly by inhibiting
proliferation and inducing apoptosis of sebocytes (Nelson et
al. 2006) and also acting as an anti-inflammatory agent
blocking the migration of polymorphonuclear leukocytes
into the skin (Wozel et al. 1991). It is believed to act by
isomerisation to all-trans-RA in tissues (Shih et al. 1986;
Tsukada et al. 2000), which then activates specific receptors
for retinoic acid (Nelson et al. 2009; Rochette-Egly and
Germain 2009). The RA receptors are members of the
nuclear receptor family regulating the transcription of sev-
eral hundreds of genes (Balmer and Blomhoff 2002) and
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Retinoic acid is synthesized endogenously from vitamin
A and acts to regulate cell proliferation and differentiation in
almost all organ systems of the body including bone, car-
diovascular, immune, reproductive and excretory systems
(Sporn et al. 1994). The nervous system is also a target
and how local synthesis of RA regulates the patterning of
gene expression during central nervous system (CNS) de-
velopment has been extensively studied (McCaffery et al.
2003). However, less is known regarding its action in the
adult CNS (Bremner and McCaffery 2008).
The hippocampus is one of the few regions in which RA
signaling is maintained through both embryonic development
and into adulthood (Misner et al. 2001). The hippocampus is
essential for the generation of episodic and spatial memory,
processes dependent on the RA-regulated functions of neuro-
nal plasticity, long-term potentiation (LTP) and neurogenesis
(McCaffery et al. 2006). Deficiency in RA created by deple-
tionofitssubstratevitaminAleadstoareductionintheability
of rats to perform in the hippocampal-dependent radial maze
task and loss of LTP (Misner et al. 2001)( C o c c oe ta l .2002),
while similarly nullmutation ofRAreceptors results inlossof
both LTP and long-term depression (LTD) as well as deficits
in spatial learning tasks (Chiang et al. 1998). An alternative
mechanism to LTP-regulating synaptic strength and plasticity,
known as synaptic scaling, is also regulated by RA, although
via a mechanism that does not involve transcriptional regula-
tion (Aoto et al. 2008) and likely requires translational control
(Poon and Chen 2008). RA is also required for neurogenesis
in the hippocampus, inducing the expression of neurotrophin
receptors (Takahashi et al. 1999) and promoting neuronal
differentiation and cell survival (Jacobs et al. 2006).
The negative effects of RA on learning and memory in
the rodent follow a U-curve shape, whereby RA deficiency
results in a decline in learning and memory and excess
similarly impairs these behaviours in both mouse (Crandall
et al. 2004) and rat (Dopheide and Morgan 2008). This may
reflect a function for RA in regulating neuronal plasticity
that relies on a patterned RA distribution, as occurs in the
embryonic CNS. Such patterns are highly sensitive to ab-
normally high or low RA (McCaffery et al. 2003).
These important effects of RA in rodents suggest that high
doses of RA may affect human brain function. In humans,
high doses of RA are given in the form of isotretinoin (13-cis
retinoic acid), a retinoid highly effective in acne therapy. In
clinical practice, there is mounting evidence strongly suggest-
ing a link between isotretinoin therapy and psychopathology
(Kontaxakis et al. 2009), although the possible link with
depression and suicide (Sundstrom et al. 2010)h a sb e e n
difficult to separate from the psychosocial effects of severe
acne (Halvorsen et al. 2011). The most frequent CNS adverse
effect is headache (Bremner and McCaffery 2008) and many
reports have identified idiosyncratic adverse events that in-
clude increases in anxiety, aggression and depression
(Bremner et al. 2011; Bremner and McCaffery 2008). Mood
change is one of the most important considerations in clinical
practice (Goodfield et al. 2010).
The effects of isotretinoin on mood and behaviour might
result from altered hippocampal function. Studies in animals
haveshown that treatment with13-cis RA results ina reduction
in hippocampal neurogenesis, a fall in performance in learning
and memory tasks (Crandall et al. 2004) as well as a decline in
thesizeofthehippocampus(McCafferyetal.2006).Reduction
in hippocampal size may be a key anatomical change in the
brainlinkedtodepressive disorder andpossiblyassociatedwith
accompanying deterioration in memory (Dere et al. 2010;
Fairhall et al. 2010; MacQueen and Frodl 2011). We
therefore investigated the influence of isotretinoin on
human learning and memory.
Materials and methods
Aims
The aims of this study were (a) to test the hypothesis that a
course of oral isotretinoin therapy would result in decline in
learning and memory as measured using the CANTAB
cognitive testing battery, (b) to generate data to inform a
larger study regarding sample size, test procedures and
outcome measures and (c) to identify cognitive tasks to be
used in future functional imaging studies.
Patients and methods
This was an open prospective observational study. As it was
not considered ethical to withhold effective treatment for
patients with severe acne, we adopted an open design with
each subject baseline test providing the baseline for a within-
subjects comparison. In a small study, variation between sub-
jects can be high and matching controls for IQ, severity of
acne and depression would require a much larger study. The
study was approved by the North Scotland Research Ethics
committee and conducted between 2008 and 2010.
Participants
We invited patients who were attending a dermatology outpa-
tient clinic for treatment of severe acne vulgaris, aged 16 or
over, in whom a clinical decision had been made to treat with
isotretinoin to participate. We excluded patients with intelli-
gence below normal who would not be able to understand the
CANTAB psychometric tests, subjects with neurological dis-
ease, epilepsy or pre-existing mental health problems, preg-
nant females, females not taking contraceptive precautions
668 Psychopharmacology (2012) 221:667–674and patients taking Dianette®, sedative or psycho-active
medication.
Intervention
Patients were treated with isotretinoin, 0.5–1 mg/kg/day, for
3–6 months until satisfactory clearance of acne lesions was
achieved. CANTAB visuospatial memory tasks, Beck’s De-
pression Inventory (BDI) and Global Acne Grade (GAG)
were assessed on three separate visits: the first immediately
prior to starting isotretinoin, the second at 3 months later
during isotretinoin therapy and with the final visit at
2 months after stopping therapy.
Procedure
We studied a limited range of cognitive tests to avoid tiring
the subject and to keep testing under 1 h. If subjects were
tired, they were permitted to take a break. The following
CANTAB tests were performed in parallel mode and are
summarized in Table 1: motor screening was designed to
relax the subject and introduce them to the touch screen and
was given at the start of each session, delayed matching to
sample (DMS) paired associate learning (PAL), pattern rec-
ognition memory (PRM) and spatial recognition memory
(SRM).
At each visit, we recorded the dose of isotretinoin (mg/kg),
any perceived subjective side effects, acne severity rated by
the GAGs score and depression using the Becks inventory.
Sample size
Based on a clinically meaningful change of 20% on a
primary outcome measure and one-sided significance
alpha00.025, we assumed a standard deviation of 20% in
the primary outcome and had a 95% power of detecting this
change with 18 patients.
Statistics
Statistics were performed using PASW statistics 18. Within-
subject comparisons were made using repeated-measures
ANOVA. Pearson’s coefficient was used to examine
correlations.
Results
Participants
Data were collected from 16 participants who were tested
before, during and after treatment with isotretinoin and a
further one who was lost to the study after treatment was
completed. There were many more male than female partic-
ipants(ratioofabout3:1)andthemaleswerebothsignificantly
younger and had more severe acne. Both groups were pre-
scribed similar doses of isotretinoin of about 0.5 mg/kg/day
(Table 2).
Depression
We first looked at whether depression, as measured by
the BDI, changed during treatment. In a paired t-test,
there were non-significant trends towards an increased
BDI score with treatment (mean [SD] before03.76
[3.36], mean during [SD]05.76 [4.19], p00.071). We
also looked at whether the size of dose correlated with
change in BDI score. This revealed a trend towards an
effect with higher dose associated with a larger change in
BDI (r00.454, p00.067, n017).
Memory
The effects of treatment on memory performance are shown
in Tables 3 and 4 and Fig. 1. A univariate repeated-measures
ANOVA showed that performance stayed unchanged for
DMS, SRM and PRM, though participants improved their
speed on the PRM task. However, performance improved
across sessions on the PAL task. Inclusion of either the BDI
baseline depression score or its amount of change as a
covariate did not alter the findings.
Relationships with dose of isotretinoin
Dose of isotretinoin correlated with improvement in the total
trial score (r00.541, p00.025), reduction in total error rate
(r00.485, p00.049) (Fig. 2) and stage completed at the first
trial (r00.523, p00.031) as percentage change from base-
line. There was no significant correlation between dose and
percent improvement in first trial memory score (r00.366,
p00.148) and average latency improvement (r00.027, p0
0.917).
Discussion
Numerous behavioural studies in animal models have pointed
to behavioural changes in rodents when the balance of RA is
disrupted, either from exposure to excess or deficiency, as
previously reviewed (Bremner et al. 2011; Olson and Mello
2010). These results indicate that a balance of RA in the brain
must be maintained and that either too much or too little is
detrimental. This study is the first to be performed to objec-
tively determine possible alterations in learning and memory
with isotretinoin treatment using a CANTAB cognitive
Psychopharmacology (2012) 221:667–674 669T
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670 Psychopharmacology (2012) 221:667–674assessmentsystemthatemploys a successionofneuropsycho-
logical tests performed on a touch screen computer.
The CANTAB tests were focused on hippocampal-based
learning and the study was designed with the hypothesis that
isotretinoin treatment for acne would have a negative influ-
ence on learning and memory, comparing the effect of the
drug on individuals before, during and after treatment. From
this comparison, no significant decline was evident in any of
the outcome measures for DMS, SRM and PRM although
several test outcomes were relatively insensitive to a mea-
sure of improvement because all groups scored a high
percentage of correct response even though there was a
trend towards worsening of the self-rated depression score,
and depression can affect memory and learning. It may be
concluded that isotretinoin does not reduce learning and
memory and our hypothesis was negated.
Remarkable, however, was the contrary finding that
memory significantly improved with treatment. This was
the case for the outcome measures of the PAL test and the
reaction times on the PRM task. However, before we can
conclude that isotretinoin improves memory, consideration
needs to be given to the possibility that this is a practice
effect, stemming simply from repeated performance of the
test, or a placebo effect since this study was run as an open
trial. Indeed the results of a recent study support our find-
ings of improved learning performance with isotretinoin
treatment (Ergun et al. 2011), but their methods were unable
to distinguish this from practice effects. In this new study,
practice effects are unlikely to account for the observed
improvement in paired associate learning for two reasons:
first, the effect is specific to only one subdomain of cogni-
tive function—other assessments do not show improvement
over time, and second, each administration of the PAL uses
trial-unique (fresh) cues. Furthermore, these tests were con-
ducted at intervals that were separated by 2 and 3 months at
a time and parallel versions were used. It would therefore
seem unlikely that participants could benefit much from
earlier experience and previous studies have not found ben-
efits of repetition.
Fowler et al. (2002) did not find any change in PAL
performance among typical controls when repeating testing
five times over a period of 2 years, though participants with
early dementia exhibited deterioration which was not evident
on standard memory tests. Lowe and Rabbit report no change
between trials separated 4 weeks apart on the PAL task (Lowe
and Rabbitt 1998). Furthermore, in separate studies, Porter et
Table 2 Summary of participant characteristics
Age
(years)
Weight
(kg)
GAGS
(baseline)
Becks depression
inventory (baseline)
Initial dose
(mg/kg)
Midtreatment
dose (mg/kg)
Males, n013 Mean (SD) 20.62 (4.31) 78.54 (14.74) 31.00 (5.29) 3.62 (3.69) 0.46 (0.13) 0.62 (0.26)
Range 15–28 60–120 21–40 0–11 0.12–0.60 0.17–1.04
Females, n04 Mean (SD) 27.75 (3.95) 63.50 (7.19) 21.00 (2.36) 4.25 (3.74) 0.53 (0.06) 0.63 (0.21)
Range 22–31 53–69 16–25 1–6 0.46–0.60 0.45–0.87
Total, n017 Mean (SD) 22.29 (5.15) 75.0 (14.69) 28.65 (6.54) 3.76 (3.36) 0.48 (0.12) 0.62 (0.24)
Range 15–31 53–120 16–40 0–11 0.12–0.60 0.17–1.04
t, p 3.09, 0.024 2.76, 0.018 7.51, 0.004 0.635, NS 0.069, NS 0.016, NS
Table 3 Effects of treatment on memory tests
Before treatment During treatment After treatment Univariate repeated-measures
ANOVA (n016)
Mean SD Range Mean SD Range Mean SD Range df FP
a
DMS total correct (all delays) 13.59 1.278 11–15 13.18 1.380 9–15 13.44 1.209 10–15 1.978 1.383 0.266
SRM percent correct 81.18 13.75 45–100 82.65 11.74 65–100 83.13 10.94 60–100 1.745 .241 0.757
PRM percent correct 90.93 10.02 71–100 94.11 5.32 83–100 91.93 8.40 79–100 1.962 .029 0.969
PAL first trial memory score 15.59 2.32 12–19 17.24 2.562 13–21 18.13 2.13 14–21 1.657 9.065 0.002
PAL stages completed on first trial 3.59 0.51 3–4 3.47 .717 2–5 3.88 0.62 3–5 1.981 3.296 0.051
PAL total errors 13.29 13.49 2–61 5.82 4.305 0–15 4.50 4.59 0–16 1.240 7.774 0.009
PAL total trials 8.76 2.66 6–17 7.41 1.417 5–11 6.81 1.42 5–10 1.420 7.296 0.008
DMS delayed matching to sample, SRM spatial recognition memory, PRM pattern recognition memory, PAL paired associate learning
aGreenhouse–Geiser correction
Psychopharmacology (2012) 221:667–674 671al.,inagroupofolderpeople,andFalconeretal.,indepressed
patients receiving electroconvulsive therapy ECT, also found
nodifferenceinPALasaresultofrepeatedtesting(Falconeret
al. 2010;P o r t e re ta l .2002).
A further indication of the direct effect of isotretinoin on
learning and memory could be determined by analysis of
correlation with the dose of isotretinoin. We therefore looked
at whether improvements in performance on memory tasks
correlated with dose of isotretinoin given during the main
period of treatment. The improvement in performance in PAL
showed a significant positive correlation with the maintenance
dose measured in milligrams per kilogram. Such a correlation
cannot be explained by either practice or placebo effects alone
since the participants were not aware of their dose.
Why might isotretinoin have an enduring positive influence
on learning? All-trans RA, to which 13-cis RA can be isomer-
ized in vivo (Shih et al. 1986; Tsukada et al. 2000), is essential
for neuronal plasticity—the capacity of individual neurons,
their connections and neural circuits to adapt to a change in
environment as well as form new memories. The most studied
aspect of this process lies at the level of single synapses and
weakens or strengthens their capacity to transmit information
Table 4 Effects of treatment on reaction times (mean correct latency)
Mean
baseline
SD Minimum Maximum Mean
during
treatment
SD Minimum Maximum Mean
after
treatment
SD Minimum Maximum df FP
a
DMS mean correct
latency (all delays)
3,079 834 1,759 5,121 2,697 712 1,163 3,799 2,723 816 1,327 3,963 1.963 2.675 .087
SRM mean correct
latency
2,002 514 1,135 3,062 1,828 333 1,130 2,595 1,735 399 925 2,300 1.904 2.217 .130
PRM mean correct
latency
1,894 455 1,142 2,873 1,731 304 1,301 2,293 1,536 272 1,154 2,028 1.880 5.759 .009
Mean overall correct
latency
2,409 558 1,479 3,614 2,187 436 1,432 2,962 2,064 408 1,187 2,654
aGreenhouse–Geiser correction, univariate repeated-measures ANOVA
Fig. 2 Scatterplot showing improvements in performance on paired
associated learning task as an effect of treatment with isotretinoin
showing that the reduction in errors in PAL is correlated with the dose
of isotretinoin (r00.485, p00.049)
Fig. 1 Effect of isotretinoin treatment on memory scores in the paired
associated learning task showing: a total errors significantly reduced
(p00.009), b total trials significantly reduced (p00.008)
672 Psychopharmacology (2012) 221:667–674from neuron to neuron to either facilitate or weaken particular
circuits to form or degrade memories. Evidence from studies in
rodents has indicated that loss of RA or block of RA signaling
via mutation of the receptor results in dramatic loss of such
Hebbian plasticity, specifically through failure of LTP and also
degradation of LTD (Chiang et al. 1998; Cocco et al. 2002;
McCaffery et al. 2006;M i s n e re ta l .2001). Recently, RA has
been found to be involved in another form of neuronal plastic-
ity. It was recognized that Hebbian plasticity such as LTP
includes positive feedback and progressively increases its
own activity. Homeostatic systems are necessary to dampen
the results of such positive feedback known as homeostatic
synaptic plasticity (Pozo and Goda 2010). The RA signaling
system provides one route for such homeostasis by direct
regulation of glutamate receptors (Aoto et al. 2008; Poon and
Chen 2008). Given that the results of this study imply that
isotretinoin has a positive influence on learning and memory,
this suggests that RA signaling in the human brain is subopti-
mal and can be improved by application of additional RA. This
differs from, for instance, mouse (Crandall et al. 2004)o rr a t
(Dopheide and Morgan 2008) in which application of isotreti-
noin, at a similar dose per body weight as used for humans,
pushes RA signaling beyond the optimal point, leading to a
decline in capacity to perform memory tasks. The reason for
suboptimal levels in the human brain is unknown but if, as
proposed, RA for the hippocampus derives from the surround-
ing meninges (Sakai et al. 2004), then the size of the human
hippocampus may limit the amount of RA reaching hippocam-
pal neurons.
ThisstudyalsopointstoanenduringeffectofRAonhuman
learning and memory. A third aspect of neural plasticity that
may lead to longer-lasting effects of isotretinoin is hippocam-
pal neurogenesis—the birth of new granule neurons in the
dentate gyrus. The process is regulated by a number of factors
including RA (Jacobs et al. 2006; Takahashi et al. 1999).
Neurogenesis and incorporation of new neurons into
hippocampal circuitry promotes several aspects of
hippocampal-dependent memory or improves pattern
separation, while inhibition of this process blocks spatial
and object recognition memory and contextual fear con-
ditioning (Imayoshi et al. 2008;J e s s b e r g e re ta l .2009;
Sahay et al. 2011;S a x ee ta l .2006). Given that RA is
required for neuronal differentiation and cell survival of
granule neurons in the dentate gyrus, if isotretinoin
promotes this process in the human hippocampus, then
the increased number of new granule neurons would
lead to long-lasting effects to promote learning and memory.
It should be noted though that not all aspects of hippocampal-
based spatial memory require neurogenesis and working
memory required for a spatial task in mice has shown to be
improved by inhibition of neurogenesis (Saxe et al. 2007). It
may be further noted that, in mouse, isotretinoin has been
reported to inhibit neurogenesis (Crandall et al. 2004).
This study found only moderate influence of isotretinon to
improve learning and memory in a dose-dependent manner.
This may be because the levels of retinoid signaling in the
young adult in this study were only marginally suboptimal.
This may not be the case, however, in older adults.
S t u d i e si na g e dm i c e( 2 1 –23 months old) have found that
the levels of brain RA receptors are lower than in younger
animals. However, this can be reversed by the treatment of
mice with RA, entirely reversing the decline in hippocampal-
dependentmemoryinanimalsandrestoringLTPinCA3ofthe
hippocampus (Enderlin et al. 1997; Etchamendy et al. 2001).
Low levels of RA signaling may occur in Alzheimer’sd i s e a s e
(Corcoran et al. 2004; Goodman and Pardee 2003) and appli-
cation of RA to a transgenic animal model of Alzheimer’s
disease leads to improved learning and spatial memory (Ding
et al. 2008). It may be the case that the effects of isotretinoin to
improve learning and memory in young adults may be far
more marked in the elderly where RA signaling may be
deficient.Thismayprovideapromisingfuturelineofresearch.
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